An unusual outbreak of monkeypox is causing concern worldwide in the shadow of the destructive Covid-19 pandemic. Both old and emerging vaccine technology could aid the fight against the outbreak.
In the wake of the world-changing Covid-19 pandemic, the World Health Organization (WHO) is voicing alarm over another unusual outbreak, this time of the viral infection monkeypox.
Monkeypox is endemic to central and west Africa, and common symptoms include headaches, fever, muscle aches, and a rash. The condition is typically mild, but can threaten pregnant women, young children, and people with weakened immune systems. The virus can spread through large respiratory droplets or by coming into close contact with a contagious skin rash.
Since the outbreak was first recorded outside of endemic regions in early May, there have been 131 confirmed monkeypox cases and another 106 suspected cases. The majority of the cases have arisen in Europe, and there are signs the virus is spreading within communities unconnected with travel to the endemic regions.
“Most of the current cases have presented with mild disease symptoms,
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.